Sweat testing infants detected by cystic fibrosis newborn screening

被引:36
作者
Parad, RB
Comeau, AM
Dorkin, HL
Dovey, M
Gerstle, R
Martin, T
O'Sullivan, BP
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Newborn Med, Boston, MA 02114 USA
[3] Childrens Hosp, Boston, MA 02115 USA
[4] Childrens Hosp, Baystate Med Ctr, Springfield, MA USA
[5] Univ Massachusetts, Worcester, MA 01605 USA
[6] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Boston, MA 02130 USA
[7] Tufts Univ New England Med Ctr, Boston, MA 02111 USA
关键词
D O I
10.1016/j.jpeds.2005.08.015
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Describe and define limitations of early pilocarpine iontophoresis (sweat testing) for cystic fibrosis (CF) newborn screening (NBS). Study design Population-based results front follow-tip of CF NBS-positive newborns. Results Insufficient quantity of sweat is more likely if the sweat test is done too early. but testing is generally successful after 2 weeks of age. Sweat chloride levels drop over the first weeks of life. CF carriers have higher sweat chloride concentrations than non-carriers. Conclusions Sweat testing can be performed effectively after 2 weeks of age for CF NBS-positive newborns. Earlier testing has a higher risk of insufficient sweat for completing testing.
引用
收藏
页码:S69 / S72
页数:4
相关论文
共 8 条
[1]   Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections [J].
Comeau, AM ;
Parad, RB ;
Dorkin, HL ;
Dovey, M ;
Gerstle, R ;
Haver, K ;
Lapey, A ;
O'Sullivan, BP ;
Waltz, DA ;
Zwerdling, RG ;
Eaton, RB .
PEDIATRICS, 2004, 113 (06) :1573-1581
[2]  
Farrell PM, 1996, PEDIATRICS, V97, P524
[3]   Nutritional benefits of neonatal screening for cystic fibrosis [J].
Farrell, PM ;
Kosorok, MR ;
Laxova, A ;
Shen, GH ;
Koscik, RE ;
Bruns, WT ;
Splaingard, M ;
Mischler, EH .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (14) :963-969
[4]   Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children [J].
Lebecque, P ;
Leal, T ;
De Boeck, C ;
Jaspers, M ;
Cuppens, H ;
Cassiman, JJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (06) :757-761
[5]  
NCCLS, 2000, SWEAT TEST SAMPL COL
[6]   Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations [J].
Padoan, R ;
Bassotti, A ;
Seia, M ;
Corbetta, C .
EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (04) :212-215
[7]   Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm [J].
Parad, RB ;
Comeau, AM .
JOURNAL OF PEDIATRICS, 2005, 147 (03) :S78-S82
[8]   Newborn screening for cystic fibrosis [J].
Parad, RB ;
Comeau, AM .
PEDIATRIC ANNALS, 2003, 32 (08) :528-535